Back to BlackRock, Inc. BlackRock, Inc.

SNOA

8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Sonoma Pharmaceuticals, Inc.

Yes. BlackRock holds 113 shares of SNOA (Sonoma Pharmaceuticals), worth $139, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. BlackRock has held SNOA in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$139

Current Shares

113

Total Value Change

-$208

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
113
0.0%
$1390.0%$1.23
0
2026-Q1
Unchanged
113
0.0%
$2410.0%$2.13
0
2025-Q4
Unchanged
113
0.0%
$4110.0%$3.64
0
2025-Q3
Unchanged
113
0.0%
$4380.0%$3.88
0
2025-Q2
Unchanged
113
0.0%
$3210.0%$2.85
0
2025-Q1
Unchanged
113
0.0%
$2470.0%$2.19
0
2024-Q4
Unchanged
113
0.0%
$3040.0%$2.69
0
2024-Q3
First report
113
-
$3470.0%$3.07
0

Other major holders of SNOA: Vanguard Group Inc., Geode Capital Management, LLC, Renaissance Technologies LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used